Bulletin
Investor Alert

Landos Biopharma Inc.

NAS: LABP

GO
/marketstate/country/us

After Hours

/zigman2/quotes/224337277/composite

$

10.40

Change

0.00 0.00%

Volume

Volume 5

Apr 22, 2021, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/224337277/composite

Today's close

$ 10.91

$ 10.40

Change

-0.51 -4.67%

Day low

Day high

$10.21

$11.12

Open
Open: 10.93

52 week low

52 week high

$8.82

$16.99

Open

Market cap

$437.68M

Average volume

196,204

P/E ratio

N/A

Rev. per Employee

N/A

EPS

N/A

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/labp

MarketWatch News on LABP

  1. Landos Biopharma started at outperform with $33 stock price target at Raymond James

    9:33 a.m. March 1, 2021

    - Tomi Kilgore

  2. Landos Biopharma started at neutral with $17 stock price target at J.P. Morgan

    9:25 a.m. March 1, 2021

    - Tomi Kilgore

  3. Bausch Health and Landos Biopharma See Activist Action

    10:30 p.m. Feb. 26, 2021

    - Barron's Online

  4. The Biotech IPO Wave Continues. 7 Stocks That Hit the Market.

    6:26 p.m. Feb. 5, 2021

    - Barron's Online

  5. A Busy Day for Biotech IPOs

    6:56 p.m. Feb. 4, 2021

    - Barron's Online

/news/nonmarketwatch/company/us/labp

Other News on LABP

  1. 10-K: LANDOS BIOPHARMA, INC.

    5:09 p.m. March 31, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  2. Wall Street Breakfast: The Week Ahead

    8:21 a.m. Feb. 28, 2021

    - Seeking Alpha

  3. Landos Biopharma Begins $100 Million IPO Push

    4:44 p.m. Jan. 22, 2021

    - Seeking Alpha

/news/pressrelease/company/us/labp

Press Releases on LABP

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.